Lin et al. previously demonstrated that Ova inhibited the metastatic ability of MDA-MB-231 breast cancer cells through suppression of p38 mitogen-activated protein kinase (MAPK) and phosphatidylinositol 3-kinase/Akt activation [21]. The gene discussed is MAPK14; the disease is breast carcinoma.